{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:22:09Z","timestamp":1787822529911,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06160-9","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:19:20Z","timestamp":1787804360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Selective Serotonin Reuptake Inhibitors as Immunomodulators: Effects on Macrophage Activation and Polarization"],"prefix":"10.1007","volume":"63","author":[{"given":"Majd H.","family":"Aldweik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0271-0594","authenticated-orcid":false,"given":"Furkan","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"6160_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00316","volume":"5","author":"JM Bennett","year":"2018","unstructured":"Bennett JM, Reeves G, Billman GE, Sturmberg JP (2018) Inflammation-nature\u2019s way to efficiently respond to all types of challenges: implications for understanding and managing \u2018the epidemic\u2019 of chronic diseases. Front Med 5","journal-title":"Front Med"},{"key":"6160_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.728810","volume":"15","author":"W Qiu","year":"2021","unstructured":"Qiu W et al (2021) Update on the relationship between depression and neuroendocrine metabolism. Front Neurosci 15","journal-title":"Front Neurosci"},{"key":"6160_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fendo.2018.00431","volume":"9","author":"SRS Ouakinin","year":"2018","unstructured":"Ouakinin SRS, Barreira DP, Gois CJ (2018) Depression and obesity: integrating the role of stress, neuroendocrine dysfunction and inflammatory pathways. Front Endocrinol 9:431","journal-title":"Front Endocrinol"},{"key":"6160_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.802581","volume":"12","author":"F Vahid-Ansari","year":"2021","unstructured":"Vahid-Ansari F, Albert PR (2021) Rewiring of the serotonin system in major depression. Front Psychiatry 12","journal-title":"Front Psychiatry"},{"key":"6160_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/FPC.0b013e32833132cb","volume":"19","author":"K Sangkuhl","year":"2009","unstructured":"Sangkuhl K, Klein TE, Altman RB (2009) Selective serotonin reuptake inhibitors pathway. Pharmacogenet Genomics 19:907\u2013909","journal-title":"Pharmacogenet Genomics"},{"key":"6160_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00005-019-00543-8","volume":"67","author":"\u0141P Sza\u0142ach","year":"2019","unstructured":"Sza\u0142ach \u0141P, Lisowska KA, Cuba\u0142a WJ (2019) The influence of antidepressants on the immune system. Arch Immunol Ther Exp (Warsz) 67:143\u2013151","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"6160_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179487","volume":"22","author":"N Koopman","year":"2021","unstructured":"Koopman N et al (2021) The multifaceted role of serotonin in intestinal homeostasis. Int J Mol Sci 22","journal-title":"Int J Mol Sci"},{"key":"6160_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020276","volume":"12","author":"A Mamilos","year":"2023","unstructured":"Mamilos A et al (2023) Macrophages: from simple phagocyte to an integrative regulatory cell for inflammation and tissue regeneration-a review of the literature. Cells 12","journal-title":"Cells"},{"key":"6160_CR9","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233:6425\u20136440","journal-title":"J Cell Physiol"},{"key":"6160_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12026-022-09350-4","volume":"71","author":"HT \u00d6nal","year":"2023","unstructured":"\u00d6nal HT, Yetkin D, Ayaz F (2023) Immunostimulatory activity of fluoxetine in macrophages via regulation of the PI3K and P38 signaling pathways. Immunol Res 71:413\u2013421","journal-title":"Immunol Res"},{"key":"6160_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050664","volume":"16","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023) GRK2 mediates macrophage polarization by regulating EP4-cAMP-pCREB signaling in ulcerative colitis and the therapeutic effect of paroxetine on mice with DSS-induced colitis. Pharmaceuticals (Basel) 16","journal-title":"Pharmaceuticals (Basel)"},{"key":"6160_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.874375","volume":"13","author":"Y Takenaka","year":"2022","unstructured":"Takenaka Y et al (2022) Profiling differential effects of 5 selective serotonin reuptake inhibitors on TLRs-dependent and -independent IL-6 production in immune cells identifies fluoxetine as preferred anti-inflammatory drug candidate. Front Pharmacol 13","journal-title":"Front Pharmacol"},{"key":"6160_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1145070","volume":"14","author":"L Ning","year":"2023","unstructured":"Ning L et al (2023) Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine. Front Immunol 14","journal-title":"Front Immunol"},{"key":"6160_CR14","volume":"16","author":"AN Patel","year":"2024","unstructured":"Patel AN, Varma J, Ganguly B (2024) Evidence of the immunomodulatory effects of selective serotonin reuptake inhibitors in patients with depression through a systematic review. Cureus 16","journal-title":"Cureus"},{"key":"6160_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1646740","volume":"16","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Xu L (2025) Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders. Front Immunol 16","journal-title":"Front Immunol"},{"key":"6160_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/02698811211069110","volume":"36","author":"N Mariani","year":"2022","unstructured":"Mariani N, Everson J, Pariante CM, Borsini A (2022) Modulation of microglial activation by antidepressants. Journal of psychopharmacology (Oxford, England) 36:131\u2013150","journal-title":"Journal of psychopharmacology (Oxford, England)"},{"key":"6160_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10787-020-00777-5","volume":"29","author":"V Dionisie","year":"2021","unstructured":"Dionisie V, Filip GA, Manea MC, Manea M, Riga S (2021) The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacology 29:75\u201390","journal-title":"Inflammopharmacology"},{"key":"6160_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115519","volume":"165","author":"A Lopatina","year":"2025","unstructured":"Lopatina A, Murugina N, Murugin V, Pashenkov M, Melnikov M (2025) The role of 5-HT2B-serotonin receptor in the modulatory effect of fluoxetine on interaction of macrophages with CD4+ T-cells in multiple sclerosis. Int Immunopharmacol 165","journal-title":"Int Immunopharmacol"},{"key":"6160_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.intimp.2015.02.029","volume":"25","author":"H Durairaj","year":"2015","unstructured":"Durairaj H, Steury MD, Parameswaran N (2015) Paroxetine differentially modulates LPS-induced TNF\u03b1 and IL-6 production in mouse macrophages. Int Immunopharmacol 25:485\u2013492","journal-title":"Int Immunopharmacol"},{"key":"6160_CR20","first-page":"977","volume":"19","author":"L Rafiee","year":"2016","unstructured":"Rafiee L, Hajhashemi V, Javanmard SH (2016) Fluvoxamine inhibits some inflammatory genes expression in LPS\/stimulated human endothelial cells, U937 macrophages, and carrageenan-induced paw edema in rat. Iran J Basic Med Sci 19:977\u2013984","journal-title":"Iran J Basic Med Sci"},{"key":"6160_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41398-023-02343-3","volume":"13","author":"Y Izumi","year":"2023","unstructured":"Izumi Y, Reiersen AM, Lenze EJ, Mennerick SJ, Zorumski CF (2023) SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids. Transl Psychiatry 13:39","journal-title":"Transl Psychiatry"},{"key":"6160_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2023.110762","volume":"125","author":"HT \u00d6nal","year":"2023","unstructured":"\u00d6nal HT, Yetkin D, Ayaz F (2023) Escitalopram\u2019s inflammatory effect on the mammalian macrophages and its intracellular mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry 125","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6160_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pbb.2016.02.005","volume":"144","author":"C Dong","year":"2016","unstructured":"Dong C et al (2016) Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav 144:7\u201312","journal-title":"Pharmacol Biochem Behav"},{"key":"6160_CR24","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1038\/cddis.2014.301","volume":"5","author":"T Omi","year":"2014","unstructured":"Omi T et al (2014) Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor. Cell Death Dis 5:e1332","journal-title":"Cell Death Dis"},{"key":"6160_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12991-025-00596-4","volume":"24","author":"Z Xie","year":"2025","unstructured":"Xie Z et al (2025) Sertraline and inflammatory markers in major depression: a systematic review and meta-analysis. Ann Gen Psychiatry 24:53","journal-title":"Ann Gen Psychiatry"},{"key":"6160_CR26","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s00213-025-06825-8","volume":"242","author":"G Min","year":"2025","unstructured":"Min G et al (2025) The effect of sertraline on depressive symptoms and serum inflammatory factors in adolescent with depression. Psychopharmacology 242:2701\u20132711","journal-title":"Psychopharmacology"},{"key":"6160_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578514","volume":"399","author":"HT \u00d6nal","year":"2025","unstructured":"\u00d6nal HT, Yetkin D, Ayaz F (2025) Exploring the immunomodulatory effects of sertraline: cytokine modulation and signaling pathway dynamics. J Neuroimmunol 399","journal-title":"J Neuroimmunol"},{"key":"6160_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.106443","volume":"14","author":"L Alexopoulou","year":"2025","unstructured":"Alexopoulou L, Irla M (2025) Toll-like receptors (TLRs) in the trained immunity era. Elife 14","journal-title":"Elife"},{"key":"6160_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662063","volume":"12","author":"YL Fu","year":"2021","unstructured":"Fu YL, Harrison RE (2021) Microbial phagocytic receptors and their potential involvement in cytokine induction in macrophages. Front Immunol 12","journal-title":"Front Immunol"},{"key":"6160_CR30","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s11033-022-08219-x","volume":"50","author":"H Mojiri-Forushani","year":"2023","unstructured":"Mojiri-Forushani H, Khajehali E, Adelipour M, Mohammadi A (2023) Inhibitory effects of fluoxetine on the secretion of inflammatory mediators and JAK\/STAT3 and JNK\/TLR4 gene expression. Mol Biol Rep 50:2231\u20132241","journal-title":"Mol Biol Rep"},{"key":"6160_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12964-024-01538-5","volume":"22","author":"S Teng","year":"2024","unstructured":"Teng S et al (2024) Antidepressant fluoxetine alleviates colitis by reshaping intestinal microenvironment. Cell Commun Signal CCS 22:176","journal-title":"Cell Commun Signal CCS"},{"key":"6160_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1248\/bpb.b24-00083","volume":"47","author":"Y Takenaka","year":"2024","unstructured":"Takenaka Y et al (2024) Structure-activity relationship analysis of fluoxetine for suppression of inflammatory cytokine production. Biol Pharm Bull 47:946\u2013954","journal-title":"Biol Pharm Bull"},{"key":"6160_CR33","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.4049\/jimmunol.1601975","volume":"199","author":"A Keselman","year":"2017","unstructured":"Keselman A, Fang X, White PB, Heller NM (2017) Estrogen signaling contributes to sex differences in macrophage polarization during asthma. J Immunol 199:1573\u20131583","journal-title":"J Immunol"},{"key":"6160_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020951","volume":"25","author":"S Enright","year":"2024","unstructured":"Enright S, Werstuck GH (2024) Investigating the effects of sex hormones on macrophage polarization. Int J Mol Sci 25","journal-title":"Int J Mol Sci"},{"key":"6160_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbi.2021.02.009","volume":"94","author":"NC Cosma","year":"2021","unstructured":"Cosma NC et al (2021) M1\/M2 polarization in major depressive disorder: disentangling state from trait effects in an individualized cell-culture-based approach. Brain Behav Immun 94:185\u2013195","journal-title":"Brain Behav Immun"},{"key":"6160_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000339109","volume":"19","author":"E Baharav","year":"2012","unstructured":"Baharav E et al (2012) Immunomodulatory effect of sertraline in a rat model of rheumatoid arthritis. NeuroImmunoModulation 19:309\u2013318","journal-title":"NeuroImmunoModulation"},{"key":"6160_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110140","volume":"144","author":"MGM Hamed","year":"2020","unstructured":"Hamed MGM, Hagag RS (2020) The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients. Med Hypotheses 144","journal-title":"Med Hypotheses"},{"key":"6160_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.23736\/S0031-0808.21.04436-0","volume":"65","author":"L Fei","year":"2023","unstructured":"Fei L et al (2023) Can selective serotonin reuptake inhibitors\/serotonin and norepinephrine reuptake inhibitor antidepressants decrease the \u2018cytokine storm\u2019 in the course of COVID-19 pneumonia? Panminerva Med 65:321\u2013326","journal-title":"Panminerva Med"},{"key":"6160_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/a-1686-9620","volume":"55","author":"MJ Nykamp","year":"2022","unstructured":"Nykamp MJ et al (2022) Opportunities for drug repurposing of serotonin reuptake inhibitors: potential uses in inflammation, infection, cancer, neuroprotection, and Alzheimer\u2019s disease prevention. Pharmacopsychiatry 55:24\u201329","journal-title":"Pharmacopsychiatry"},{"key":"6160_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.33090","volume":"4","author":"T Oskotsky","year":"2021","unstructured":"Oskotsky T et al (2021) Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open 4","journal-title":"JAMA Netw Open"},{"key":"6160_CR41","first-page":"578","volume":"29","author":"J Deng","year":"2023","unstructured":"Deng J et al (2023) Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 29:578\u2013586","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"6160_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00406-021-01326-z","volume":"272","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Suzuki T, Hashimoto K (2022) Old drug fluvoxamine, new hope for COVID-19. Eur Arch Psychiatry Clin Neurosci 272:161\u2013163","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"6160_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/a-1717-2381","volume":"55","author":"JK Mueller","year":"2022","unstructured":"Mueller JK, Riederer P, M\u00fcller WE (2022) Neuropsychiatric drugs against COVID-19: what is the clinical evidence? Pharmacopsychiatry 55:7\u201315","journal-title":"Pharmacopsychiatry"},{"key":"6160_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103036","volume":"80","author":"P Jittamala","year":"2025","unstructured":"Jittamala P et al (2025) Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). EClinicalMedicine 80","journal-title":"EClinicalMedicine"},{"key":"6160_CR45","doi-asserted-by":"publisher","first-page":"111437","DOI":"10.1016\/j.biopha.2021.111437","volume":"138","author":"JF Creeden","year":"2021","unstructured":"Creeden JF et al (2021) Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection. Biomed Pharmacother Biomedecine Pharmacother 138:111437","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"6160_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s44192-023-00036-3","volume":"3","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K (2023) Overview of the potential use of fluvoxamine for COVID-19 and long COVID. Discov Ment Health 3:9","journal-title":"Discov Ment Health"},{"key":"6160_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.csbj.2023.12.045","volume":"24","author":"H Sidky","year":"2024","unstructured":"Sidky H et al (2024) Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19. Comput Struct Biotechnol J 24:115\u2013125","journal-title":"Comput Struct Biotechnol J"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06160-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06160-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:02:23Z","timestamp":1787821343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06160-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6160"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06160-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"859"}}